Cancer Drug Production Using Engineered Tobacco

  • Author:
  • Published: 02 December 2019
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Journal of the American Chemical Society/ACS Publications
  • Associated Societies: American Chemical Society (ACS), USA
thumbnail image: Cancer Drug Production Using Engineered Tobacco

Etoposide (pictured) is used as a drug against different types of cancer. It is on the World Health Organization’s (WHO) list of essential medicines. The drug is currently produced semi-synthetically based on an extract from the Himalayan mayapple, which is considered endangered. There have been several etoposide shortages in the past. Thus, an alternative path to the drug is needed.

Elizabeth S. Sattely, Stanford University, CA, USA, and colleagues have developed a way to produce (−)-deoxypodophyllotoxin, a precursor to etoposide, on a milligram scale. For this, the team used an engineered biosynthetic pathway in tobacco plants. For this "foreign-host" approach, the researchers used an Agrobacterium strain to transport the 16 necessary genes for the synthesis into tobacco leaves. These genes cause a higher production of coniferyl alcohol and encode the enzymes needed to convert it to the product. The coniferyl alcohol is dimerized to give (+)-pinoresinol, which is further processed to the desired (−)-deoxypodophyllotoxin.

The team achieved yields of 4.3 mg (−)-deoxypodophyllotoxin per gram of dry plant weight. According to the researchers, the synthesis is the longest natural product pathway reconstituted in a plant heterologous host so far. The work could help to synthesize analogues of etoposide, ensure its supply, and promote the development of tobacco as a platform for the production of other plant-derived drugs.

Also of Interest



Article Views: 2317

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH